Jump to Navigation
Trends and Sentiments
Comments and Analysis
Risk rising: Why investing gurus are worried that this...
Got stock market angst? A bit of rebalancing may be the...
Today In SA PRO: Friday, August 22
TOP Ships: Deep Discount To NAV Presents Opportunity
DDA housing scheme: Draw of lots for 25,000 flats by...
Apple iPhone 6 production 'hit' after screen...
Aid convoy to Ukraine crosses back into Russia
Salesforce.com: Profit Outlook Remains Cloudy
Gold Actually Thrives In Rising-Rate Environments
Russian aid trucks 'leave Ukraine'
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
23/8/2014: Two charts: US Oil
U.S. considers air strikes on ISIS targets in...
EUR/GBP: 1.2515 USD/EUR: 1.3242 JPY/USD: 103.925
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions